Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study page now returns a 403 Forbidden error, replacing the usual study record content with an access-denied screen while preserving site chrome like the header and footer.SummaryDifference21%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag at the bottom updates from v3.6.5 to v3.6.6. This signals a platform version update rather than a change to study content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe previously unavailable study page now loads the full study record for NCT03666325, including the Study Details and related sections. It also adds glossary terms and metadata to support indexing and navigation.SummaryDifference69%

- Check50 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, indicating a minor administrative update rather than substantive changes to study details.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new revision of the Study Details page. This is a metadata/version change and does not alter the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page's revision was updated from v3.6.2 to v3.6.3. This reflects a small backend/template update rather than changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.